Skip to content
-
Subscribe to our newsletter & never miss our best posts. Subscribe Now!
Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

Itfy.in

At Itfy, we are dedicated to revolutionizing the way you receive news. Our mission is to provide timely, accurate, and personalized news updates using cutting-edge AI technology. Stay informed, stay ahead with us.

  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
  • Home
  • News Updates
    • Latest News
    • Entertainment News
    • Northeast News
  • Technology
    • Digital Transformation
    • Artificial Intelligence
    • Machine Learning
    • Generative AI
    • Cybersecurity
  • Education & Growth
    • Education
    • Lifelong Learning
    • Parenting
    • Career Growth
  • Startup & Entrepreneurship
    • Remote Work
    • Startups
    • Digital Marketing
    • Social Media
    • Entrepreneurship
    • Lean Thinking
    • Personal Finance
  • Climate Justice
    • Climate Tech
  • Health & Wellness
    • Mental Health
  • Tourism
Close

Search

  • https://www.facebook.com/
  • https://twitter.com/
  • https://t.me/
  • https://www.instagram.com/
  • https://youtube.com/
Subscribe
Home/News/Transforming Hope: Tracking GLP-1 Use for Empowering Breast Cancer Care
News

Transforming Hope: Tracking GLP-1 Use for Empowering Breast Cancer Care

By adminitfy
December 15, 2025 2 Min Read

Obesity is a recognized risk factor for both the onset and recurrence of breast cancer. In recent advancements, glucagon-like peptide 1 (GLP-1) receptor agonists have emerged as effective options for weight management. At the 2025 San Antonio Breast Cancer Symposium, researchers unveiled a pivotal study that explored the real-world application of GLP-1 among breast cancer patients, examining its connections to clinical outcomes, social determinants of health (SDOH), and circulating tumor DNA (ctDNA) results.

This extensive study analyzed electronic health records from over 708,000 breast cancer patients diagnosed between January 2011 and February 2025. Utilizing artificial intelligence to assist in data extraction, researchers assessed documented GLP-1 usage, relevant clinical and sociodemographic characteristics, and correlations with ctDNA testing and positivity rates.

Interestingly, 7.6% of the patients in the study were found to have documented GLP-1 usage, primarily for issues related to diabetes, weight loss, cardiovascular health, or obstructive sleep apnea. The therapy was notably more prevalent among patients with a body mass index (BMI) of 30 or higher, non-Latinx Black patients, individuals using telemedicine, and those residing in rural areas. In contrast, utilization was markedly lower among older adults aged over 75, patients with advanced-stage disease (stage IV), those with hormone receptor-negative and HER2-negative tumors, as well as among Latinx and Asian patients. Additionally, patients with limited English proficiency and those receiving care within community medical centers rather than academic institutions exhibited lower GLP-1 use.

The study also drew attention to a potential association between GLP-1 usage and tumor activity. Patients using GLP-1 experienced significantly higher rates of ctDNA testing (2.8% versus 1.5%) and lower positivity rates for ctDNA (25.8% versus 31.6%). These findings suggest that GLP-1 therapy may be linked to a reduction in circulating tumor activity, which raises compelling questions regarding whether these medications could have a supportive role in oncology care beyond their primary purpose of weight management.

The researchers emphasized the broader implications of their findings, noting that clinical factors, sociodemographic differences, and SDOH significantly affect the use of GLP-1 therapies. They highlighted the existing disparities in access to such treatments, underscoring the necessity for further studies to determine whether GLP-1 medications can directly improve breast cancer outcomes. Ensuring equitable access to supportive therapies for diverse populations is critical.

This analysis represents one of the most extensive investigations into the real-world use of GLP-1 in breast cancer, offering valuable insights into its potential benefits and raising new avenues for future research. As the dialogue around obesity and its connection to cancer becomes increasingly relevant, studies like this provide essential data that could influence treatment approaches and health policies moving forward.

Reference: Ryals CA et al. Real-world glucagon-like peptide 1 use and association with clinical characteristics, social determinants, and circulating tumor DNA positivity in patients with breast cancer. Abstract PD8-07-02. SABCS 2025; 9-12 December.

Original Source: https://www.emjreviews.com/oncology/news/sabcs-2025-tracking-glp-1-use-in-breast-cancer-care/
Category :
Tags:
Publish Date: 2025-12-15 03:45:00

Author

adminitfy

Follow Me
Other Articles
Previous

Exclusive: Allen Unveils the Heartwarming Bond Between Men in a Blockbuster Win!

Experience the Thrill: Expedition 33 Shines at The Game Awards!
Next

Experience the Thrill: Expedition 33 Shines at The Game Awards!

No Comment! Be the first one.

Leave a Reply Cancel reply

You must be logged in to post a comment.

Search...

Recent Posts

  • ESPN’s Blockbuster Subscriber Crash Unveiled: 54M Now-Nearly Half Its 2011 Peak-Cord-Cutting Buzz Explained
    by adminitfy
    November 19, 2026
  • Empowering Northeast India: CII’s CSR Connect Event Ignites Social Development
    by adminitfy
    July 3, 2024
  • Urgent Crisis: Northeast on High Alert as Death Toll Tragically Rises in Assam
    by adminitfy
    July 3, 2024
  • Triumphant Breakthrough: Security Forces Successfully Capture 4 Insurgents in Manipur Operation
    by adminitfy
    July 3, 2024

Welcome to the ultimate source for fresh perspectives! Explore curated content to enlighten, entertain and engage global readers.

  • Facebook
  • X
  • Instagram
  • LinkedIn

Latest Posts

  • ESPN’s Blockbuster Subscriber Crash Unveiled: 54M Now-Nearly Half Its 2011 Peak-Cord-Cutting Buzz Explained
  • Horoscope Today, Nov 19, 2026: Your Astrological Predictions Await
  • NASA’s Voyager 1 Hits Record One Light-Day Distance After 50 Years
  • Alleged Russian Agent Arrested for Surveillance of US Tech Firm
  • Anthropic’s IPO and the New Economics of AI Platform Power
  • November 2026 (583)
  • October 2026 (646)
  • September 2026 (524)
  • August 2026 (1001)
  • July 2026 (986)
  • June 2026 (963)
  • May 2026 (922)
  • April 2026 (1525)
  • March 2026 (1522)
  • February 2026 (1252)
  • January 2026 (968)
  • December 2025 (942)
  • November 2025 (853)
  • October 2025 (869)
  • September 2025 (733)
  • August 2025 (810)
  • July 2025 (720)
  • June 2025 (1244)
  • May 2025 (2201)
  • April 2025 (1481)
  • March 2025 (2020)
  • February 2025 (1159)
  • January 2025 (1440)
  • December 2024 (1499)
  • November 2024 (1771)
  • October 2024 (1815)
  • September 2024 (1750)
  • August 2024 (1458)
  • July 2024 (1268)

Contact

Email

info@itfy.in

Location

INDIA

Copyright 2026 — Itfy.in. All rights reserved.